Content about Pharmaceutical industry

March 17, 2010
GPhA: Omission of 'pay-for-delay' deals in health bill 'good news for American consumers'

A ban on patent settlements between branded and generic drug companies appears to have been...

March 17, 2010
Lilly comments on drug theft at Connecticut facility

Drugs stolen from an Eli Lilly warehouse in Connecticut Sunday unlikely are to make it...

March 17, 2010
PhRMA names new chairman

The Pharmaceutical Research and Manufacturers of America elected Pfizer president and CEO Jeffrey Kindler as...

March 17, 2010
Roche calls its R&D status 'uniquely positioned'

Roche leaders appear confident about their company’s research and development position, with several investigational drugs...

March 17, 2010
Teva to acquire Ratiopharm

Teva Pharmaceutical Industries beat out Pfizer in the race to acquire German generic drug maker...

March 16, 2010
FDA shuts down unapproved Glenmark, Konec drugs

The Food and Drug Administration has ordered two generic drug companies to stop marketing unapproved...

March 16, 2010
MiddleBrook expanding promotion of Moxatag through IncreaseRx program

MiddleBrook Pharmaceuticals plans to promote its extended-release antibiotic by expanding a Web-based marketing program, the...

March 16, 2010
Pending court ruling, Teva to delay marketing Temodar generic

Teva Pharmaceutical Industries will start marketing its version of a brain tumor drug only if...

March 15, 2010
FDA issues complete response letter for MannKind's Afrezza

The Food and Drug Administration did not approve an application from MannKind Corp. for a...

March 15, 2010
Mylan, Takeda reach agreement on Actos, Actoplus Met patents

Mylan has settled patent litigation cases with Takeda concerning two diabetes drugs, the generic drug...

March 15, 2010
NCPA: Drug manufacturers should pay rebates in DoD's Tricare program

The National Community Pharmacists Association expressed support of the U.S. Department of Defense's efforts to...

March 15, 2010
Teva seeks to market Shire's ADHD drug

Teva is hoping to get a generic drug for treating attention deficit hyperactivity disorder into...

March 15, 2010
Watson receives FDA approval for Cardizem LA generic

The Food and Drug Administration has approved a Watson Pharmaceuticals drug for hypertension, Watson announced...

March 14, 2010
Bausch & Lomb recruits two Schering-Plough leaders as CEO, chairman

Bausch & Lomb on Monday recruited two former Schering-Plough senior leaders to take the reigns...

March 14, 2010
FDA demands REMS for Bydureon

Drug makers Eli Lilly, Amylin Pharmaceuticals and Alkermes encountered a speed bump in their efforts...

March 14, 2010
Ranbaxy to launch generic Actos

India’s Ranbaxy Labs will launch a generic version of a diabetes drug in two years,...

March 14, 2010
Rx suppliers prepare for patent-protection storm

Drug companies stand to lose a lot of money in the coming years, as the...

March 11, 2010
Caraco launches colon, rectal cancer generic

Caraco Pharmaceutical Labs has launched a generic version of a drug for treating colon and...

March 11, 2010
CHPA president to retire, organization seeks new leader

Linda Suydam, Consumer Healthcare Products Association president, announced her retirement Friday morning at the over-the-counter...

March 10, 2010
FDA accepts approval application for lurasidone

The Food and Drug Administration has accepted an approval application for a new drug to...

March 10, 2010
Sanofi-Aventis completes acquisition of Chattem

A leading global pharmaceutical company has completed its acquisition of a consumer healthcare products manufacturer....

March 9, 2010
Abbott to boost business with Facet acquisition

Abbott will acquire Facet Biotech for $450 million, the drug maker announced Wednesday....

March 9, 2010
Walgreens pursuing Rx contract with Delta Air Lines, report says

Walgreens is reported to be negotiating with Delta Air Lines on a contract to provide...

March 9, 2010
Watson reaches patent settlement for Actos generic

MORRISTOWN, N.J. Watson Pharmaceuticals and Takeda Pharmaceuticals North America have settled a patent litigation case...

March 8, 2010
Bristol-Myers Squibb, AstraZeneca announce postmarketing study for Onglyza

Two drug makers hope to find out how well a diabetes drug works in treating...

© 2013 Drug Store News. All Rights Reserved.